Quick Picks - Shares of Zalicus Inc. (NASDAQ:ZLCS) sunk 40% before the open Monday morning after the company announced it would be discontinuing development of its Rheumatoid Arthritis … Continue Reading
Read NowQuick Picks - ImmunoCellular Therapeutics (NYSEAMEX:IMUC) is showing big gains on Thursday after the Maxim Group initiated coverage of the company with a Buy rating and a price … Continue Reading
Read NowQuick Picks - On news of an upcoming conference presentation, Chelsea Therapeutics (NASDAQ:CHTP) is up 16% in afternoon trading at triple its 30-day average volume. Chelsea will present … Continue Reading
Read NowQuick Picks - Shares of BioSante Pharmaceuticals (NASDAQ:BPAX) are up 9% Tuesday on news that the company will be concluding a Phase III safety study of LibiGel, a … Continue Reading
Read NowQuick Picks - On news Tuesday of a $500M shelf registration, MannKind Corp. (NASDAQ:MNKD) is down 7% just after the market’s open. The S-3 registration allows the company … Continue Reading
Read NowQuick Picks - The Australian diagnostics company Genetic Technologies (NASDAQ:GENE)(ASX:GTG) is giving up gains from Wednesday, down 6% on the day to $3.48. The middle of the week … Continue Reading
Read NowQuick Picks - After Stifel Nicolaus initiated a Buy rating on Geron Corporation (NASDAQ:GERN) Thursday morning, shares are up 10% to $2.68. The $4 target price initially created … Continue Reading
Read Now